Gorham's massive osteolysis

The role of radiation therapy and a review of the literature

Susan F. Dunbar, Andrew Rosenberg, Henry Mankin, Daniel Rosenthal, Herman D. Suit

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Purpose: This paper reviews the natural history and management of patients with Gorham's disease and presents four cases treated at The Massachusetts General Hospital since 1965. Gorham's disease is characterized by localized endothelial proliferation which results in destruction and resorption of bone. The etiology is undefined. There is no evidence of a malignant, neuropathic, or infectious component. This disease is progressive in most patients, but in occasional instances the process has been noted to be self-limited. The principal treatment modalities are surgery and radiation therapy. Methods and Material: Since 1965, four patients with Gorham's Disease have been treated at the Massachusetts General Hospital. Three received definitive radiation therapy in doses ranging from 31.5 to 45 Gy. The fourth patient underwent surgery primarily. Results: Three patients are currently alive and fully functional with no evidence of disease at last follow-up. The fourth patient died of progressive disease despite treatment with both radiation therapy and surgery. Conclusion: The prognosis for patients with Gorham's disease is generally good unless vital structures are involved. Due to the rarity of this entity, there is no standard therapy. Definitive radiation therapy in moderate doses (40-45 Gy in 2 Gy fractions) appears to result in a good outcome and few long-term complications.

Original languageEnglish
Pages (from-to)491-497
Number of pages7
JournalInternational journal of radiation oncology, biology, physics
Volume26
Issue number3
DOIs
StatePublished - Jun 15 1993
Externally publishedYes

Fingerprint

Essential Osteolysis
radiation therapy
Radiotherapy
surgery
General Hospitals
therapy
etiology
dosage
prognosis
Bone Resorption
Natural History
bones
destruction
Therapeutics
histories

Keywords

  • Gorham's disease
  • Osteolysis
  • Radiation therapy
  • Reossification
  • Spontaneous regression
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Gorham's massive osteolysis : The role of radiation therapy and a review of the literature. / Dunbar, Susan F.; Rosenberg, Andrew; Mankin, Henry; Rosenthal, Daniel; Suit, Herman D.

In: International journal of radiation oncology, biology, physics, Vol. 26, No. 3, 15.06.1993, p. 491-497.

Research output: Contribution to journalArticle

Dunbar, Susan F. ; Rosenberg, Andrew ; Mankin, Henry ; Rosenthal, Daniel ; Suit, Herman D. / Gorham's massive osteolysis : The role of radiation therapy and a review of the literature. In: International journal of radiation oncology, biology, physics. 1993 ; Vol. 26, No. 3. pp. 491-497.
@article{86fd70120e254288abed3ba44bc94510,
title = "Gorham's massive osteolysis: The role of radiation therapy and a review of the literature",
abstract = "Purpose: This paper reviews the natural history and management of patients with Gorham's disease and presents four cases treated at The Massachusetts General Hospital since 1965. Gorham's disease is characterized by localized endothelial proliferation which results in destruction and resorption of bone. The etiology is undefined. There is no evidence of a malignant, neuropathic, or infectious component. This disease is progressive in most patients, but in occasional instances the process has been noted to be self-limited. The principal treatment modalities are surgery and radiation therapy. Methods and Material: Since 1965, four patients with Gorham's Disease have been treated at the Massachusetts General Hospital. Three received definitive radiation therapy in doses ranging from 31.5 to 45 Gy. The fourth patient underwent surgery primarily. Results: Three patients are currently alive and fully functional with no evidence of disease at last follow-up. The fourth patient died of progressive disease despite treatment with both radiation therapy and surgery. Conclusion: The prognosis for patients with Gorham's disease is generally good unless vital structures are involved. Due to the rarity of this entity, there is no standard therapy. Definitive radiation therapy in moderate doses (40-45 Gy in 2 Gy fractions) appears to result in a good outcome and few long-term complications.",
keywords = "Gorham's disease, Osteolysis, Radiation therapy, Reossification, Spontaneous regression, Surgery",
author = "Dunbar, {Susan F.} and Andrew Rosenberg and Henry Mankin and Daniel Rosenthal and Suit, {Herman D.}",
year = "1993",
month = "6",
day = "15",
doi = "10.1016/0360-3016(93)90968-2",
language = "English",
volume = "26",
pages = "491--497",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Gorham's massive osteolysis

T2 - The role of radiation therapy and a review of the literature

AU - Dunbar, Susan F.

AU - Rosenberg, Andrew

AU - Mankin, Henry

AU - Rosenthal, Daniel

AU - Suit, Herman D.

PY - 1993/6/15

Y1 - 1993/6/15

N2 - Purpose: This paper reviews the natural history and management of patients with Gorham's disease and presents four cases treated at The Massachusetts General Hospital since 1965. Gorham's disease is characterized by localized endothelial proliferation which results in destruction and resorption of bone. The etiology is undefined. There is no evidence of a malignant, neuropathic, or infectious component. This disease is progressive in most patients, but in occasional instances the process has been noted to be self-limited. The principal treatment modalities are surgery and radiation therapy. Methods and Material: Since 1965, four patients with Gorham's Disease have been treated at the Massachusetts General Hospital. Three received definitive radiation therapy in doses ranging from 31.5 to 45 Gy. The fourth patient underwent surgery primarily. Results: Three patients are currently alive and fully functional with no evidence of disease at last follow-up. The fourth patient died of progressive disease despite treatment with both radiation therapy and surgery. Conclusion: The prognosis for patients with Gorham's disease is generally good unless vital structures are involved. Due to the rarity of this entity, there is no standard therapy. Definitive radiation therapy in moderate doses (40-45 Gy in 2 Gy fractions) appears to result in a good outcome and few long-term complications.

AB - Purpose: This paper reviews the natural history and management of patients with Gorham's disease and presents four cases treated at The Massachusetts General Hospital since 1965. Gorham's disease is characterized by localized endothelial proliferation which results in destruction and resorption of bone. The etiology is undefined. There is no evidence of a malignant, neuropathic, or infectious component. This disease is progressive in most patients, but in occasional instances the process has been noted to be self-limited. The principal treatment modalities are surgery and radiation therapy. Methods and Material: Since 1965, four patients with Gorham's Disease have been treated at the Massachusetts General Hospital. Three received definitive radiation therapy in doses ranging from 31.5 to 45 Gy. The fourth patient underwent surgery primarily. Results: Three patients are currently alive and fully functional with no evidence of disease at last follow-up. The fourth patient died of progressive disease despite treatment with both radiation therapy and surgery. Conclusion: The prognosis for patients with Gorham's disease is generally good unless vital structures are involved. Due to the rarity of this entity, there is no standard therapy. Definitive radiation therapy in moderate doses (40-45 Gy in 2 Gy fractions) appears to result in a good outcome and few long-term complications.

KW - Gorham's disease

KW - Osteolysis

KW - Radiation therapy

KW - Reossification

KW - Spontaneous regression

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0027200217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027200217&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(93)90968-2

DO - 10.1016/0360-3016(93)90968-2

M3 - Article

VL - 26

SP - 491

EP - 497

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -